This case report describes the simultaneous occurrence of autoimmune thrombocytopenia and the lupus anticoagulant in a patient with primary adenocarcinoma of the bronchus. Treatment with corticosteroids and plasmapheresis resulted in a return to normal of the partial thromboplastin time and the disappearance of the platelet antibodies. The carcinoma was inoperable.
Introduction
Both lupus anticoagulant and autoimmune thrombocytopenia may occur in association with malignancy. The lupus anticoagulant has been reported in patients with caecal, cervical, prostatic and metastatic adenocarcinomata.'" Autoimmune thrombocytopenia has been described in lymphoma and chronic lymphocytic leukaemia.3 '4 We report both of these haematological disturbances in a patient with primary adenocarcinoma of the bronchus.
Case report
A 68 year old retired office worker presented with recent spontaneous epistaxis, bruising and a right hemiplegia. He also complained of left sided chest pain, cough and haemoptysis, which had failed to respond to three recent courses of antibiotics. He had lost a stone in weight and had smoked thirty cigarettes a day until 1967. On examination, he was obese and had extensive bruising affecting his face, neck and right arm. There was a widespread purpuric rash with splinter haemorrhages ofhis finger nails. Air The platelet count rose to 40 x 109/l, the platelet antibody disappeared and the PTT returned to normal (see Figure 1 ). Movement in his right arm improved considerably and the patient had no further bruising or bleeding and felt well 9 Since the presence of the lupus anticoagulant per se may lead to thrombocytopenia, the interpretation of the cause of clinical symptoms when both the lupus anticoagulant and autoimmune thrombocytopenia are present is complex.
Our patient's hemiplegia may have been due to a cerebral arterial thrombotic episode, associated with the lupus anticoagulant or to an intracerebral bleed, associated with his severe immune thrombocytopenia. Additional contributory factors, however, cannot be excluded. The fact that the hemiplegia recovered during steroid therapy, in association with the disappearance of both the lupus anticoagulant and platelet antibodies does not clarify the mechanism, but makes it seem, more likely that his stroke was due to thrombocytopenia and that a rise in platelet count above a critical level prevented further episodes of The patient's initial presentation with spontaneous bleeding is probably attributable to his severe thrombocytopenia and recovered when a stable, higher platelet count was reached.
Anticardiolipin antibody is also thought to be antiphospholipid and a close correlation has been found between both IgG and IgM anticardiolipin antibodies and the lupus anticoagulant.'3 Both are frequently accompanied by a false positive VDRL. Anticardiolipin antibody has also been described in the thrombocytopenia of systemic lupus erythematosus and related autoimmune disorders'4 and in autoimmune thrombocytopenia although the correlation is less in the latter condition. '5 The four antibody reactions in our patient are most commonly found either individually or in combination, in patients suffering from systemic lupus erythematosus and other related autoimmune disorders. Antinuclear factor and anti-DNA antibodies in our patient remained persistently negative and no clinical evidence of systemic lupus erythematosus was found.
Autoimmune thrombocytopenia is commonly found in lymphoma and chronic lymphatic leukaemia but is uncommon in adenocarcinoma. We suggest that this patient's autoimmune manifestations are further examples ofthe paraneoplastic syndrome described by Grunwald et al. '6 and that the autoimmune response is stimulated by the tumour. This case study shows that although the patient's adenocarcinoma was inoperable, the distressing haematological symptoms disap-peared with treatment, reinforcing the value of low dose corticosteroids in the management of some cases of autoimmune complications associated with malignancy.
